Health Condition 1: N30-N39- Other diseases of the urinary system
Conditions
Interventions
Intervention1: Jawarish Kundur: 5 gm BD administered orally with water twice daily for 6 weeks.
Control Intervention1: Oxybutynin: 5 mg administered orally with water twice daily for 6 weeks
Sponsors
Central Council for research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: History of all or any of the following symptoms for more than six months 1. Urgency of urine 2. Incontinence 3. Frequency 4. Nocturia
Exclusion criteria
Exclusion criteria: The following patients will be excluded from the study 1.Patients with history of Bladder calculus 2.Patients with Urinary tract infections 3.Known case of Benign Prostrate Hypertrophy 4.Known case of Uterine prolapse •Patients with Rectocele/cystocele •Patients with Cystitis •Pregnant and lactating females •Known case of Neoplasm •Known case of with Hepatic/Cardiac diseases •Known case of Multiple sclerosis and Spinal cord injury. •Medications (anticholinergic, antidepressant, psychotropic, or alpha-blocker)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and after 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in OABSS, SF36, CES-D scoreTimepoint: 2 weeks | — |
Countries
India
Contacts
Public ContactDr Ahmed Minhajuddin
National Research Institute of Unani Medicine for Skin Disorders, Hyderabad
Outcome results
None listed